SPRY Insider Holders & Insider Ownership - ARS Pharmaceuticals Inc.

List of insiders holdings for ARS Pharmaceuticals Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. 10% Owner	2025-07-22 19:38:15	8,633,537 0	8,633,537	Form 13D
2	ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director	2024-08-28 16:26:15	0 8,288,510	8,288,510	Form 4
3	Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner	2024-06-17 20:47:57	5,219,124 0	5,219,124	Form 13D
4	Schroeder Thilo Director	2020-12-08 20:48:12	0 1,910,029	1,910,029	Form 4
5	Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner	2025-01-03 16:30:43	261,900 767,600	1,029,500	Form 4
6	Lowenthal Richard E PRESIDENT AND CEO 10% Owner	2025-01-03 16:30:37	767,600 261,900	1,029,500	Form 4
7	Scott Kathleen D. Chief Financial Officer	2025-05-22 17:00:06	759,754 8,250	768,004	Form 4
8	Alexandria Venture Investments LLC 10% Owner	2020-12-08 16:36:52	699,412 0	699,412	Form 4
9	Karas Eric Chief Commercial Officer	2025-07-03 16:21:24	554,903 0	554,903	Form 4
10	Pepe Jeffrey C. Interim CEO and GC	2022-09-08 17:04:48	427,750 0	427,750	Form 3
11	Fitzpatrick Alexander A Chief Legal Officer	2025-05-22 17:00:13	289,613 0	289,613	Form 4
12	Chakma Justin Chief Business Officer	2025-01-03 16:30:36	274,100 0	274,100	Form 4
13	Dorsey Brian Chief Operating Officer	2025-01-03 16:30:44	261,900 0	261,900	Form 4
14	Piazza Jonathan Chief Financial Officer	2022-05-04 17:16:04	156,608 0	156,608	Form 4
15	Odegard Valerie President and CSO	2022-05-04 17:12:32	152,106 0	152,106	Form 4
16	Hunder Naomi Chief Medical Officer	2022-05-04 17:07:01	140,782 0	140,782	Form 4
17	Presidio Management Group XII L.L.C. U.S. Venture Partners XII L.P. U.S. Venture Partners XII-A L.P. Tansey Casey M 10% Owner	2022-01-27 15:05:08	110,120 0	110,120	Form 13D
18	Hawkinson Russ Sr. Vice President of Finance	2022-05-04 17:00:02	93,921 0	93,921	Form 4
19	Shawver Laura Director	2025-06-27 16:30:06	30,000 0	30,000	Form 4
20	SCHNEIDER PHILLIP M Director	2025-06-27 16:30:10	30,000 0	30,000	Form 4
21	SAUNDERS BRENT L Director	2025-06-27 16:30:13	30,000 0	30,000	Form 4
22	Islam Saqib Director	2025-06-27 16:30:18	30,000 0	30,000	Form 4
23	Kelly Michael Director	2025-06-27 16:30:19	30,000 0	30,000	Form 4
24	Shah Pratik Director	2025-06-27 16:30:23	30,000 0	30,000	Form 4
25	Thompson Peter A. Director	2025-06-27 16:30:15	30,000 0	30,000	Form 4
26	Dadoo Rajeev Director	2025-06-27 16:43:08	30,000 0	30,000	Form 4
27	RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner	2025-06-27 17:21:48	0 30,000	30,000	Form 4
28	CAPPS VICKIE L Director	2022-06-13 19:27:09	18,000 0	18,000	Form 4
29	HERSHBERG ROBERT Director	2022-06-13 19:31:19	18,000 0	18,000	Form 4
30	ROOT JONATHAN D Director	2022-06-13 19:48:06	18,000 0	18,000	Form 4
31	Powell Andrew Kenneth William Director	2022-06-13 19:44:15	18,000 0	18,000	Form 4
32	Koehler Maria Director	2022-06-13 19:39:13	18,000 0	18,000	Form 4
33	LEFF JONATHAN S Director	2022-11-10 17:00:26	0 0	0	Form 3

Insider Holders & Insider Ownership - ARS Pharmaceuticals Inc. (SPRY)